UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044291
Receipt number R000050592
Scientific Title A Clinical Trial on the Physical and Mental Effects of COVID-19 vaccination in Patients with Chronic Respiratory Failure.
Date of disclosure of the study information 2021/05/22
Last modified on 2023/11/23 18:40:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Clinical Trial on the Physical and Mental Effects of COVID-19 vaccination in Patients with Chronic Respiratory Failure.

Acronym

Effects of a COVID-19 vaccination on patients with chronic respiratory failure.

Scientific Title

A Clinical Trial on the Physical and Mental Effects of COVID-19 vaccination in Patients with Chronic Respiratory Failure.

Scientific Title:Acronym

Effects of a COVID-19 vaccination on patients with chronic respiratory failure.

Region

Japan


Condition

Condition

Chronic Respiratory Failure

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The COVID-19 vaccine will be used to evaluate the presence and severity of adverse reactions to vaccination in patients with chronic respiratory failure and their relationship to background factors.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Vital signs such as temperature, pulse, blood pressure, respiratory rate, and SpO2, subjective symptoms (drowsiness, lightheadedness, calmness, comfort, breathlessness, lethargy, headache, feverishness, inoculation site pain, and general pain) assessed by 100mm VAS, inoculation site reaction, systemic reaction, suspected adverse reaction, and serious adverse events

Key secondary outcomes

Confirmation of COVID-19 incidence at 4 weeks after the last vaccination, background factors such as underlying disease, age, gender, lung function, arterial blood gas, oxygen prescription volume, and NPPV prescription status and content of the vaccines


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with chronic respiratory failure and receiving oxygen therapy or artificial respiration therapy

Key exclusion criteria

Patients with a poor prognosis, serious general condition, or other patients judged inappropriate by the physician.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Kensuke
Middle name
Last name Sumi

Organization

National Hospital Organization Minami Kyoto Hospital

Division name

Department of Respiratory Medicine

Zip code

6100113

Address

11 Naka Ashihara, Joyo City, Kyoto Prefecture

TEL

0774520065

Email

kensukesumi@gmail.com


Public contact

Name of contact person

1st name Kensuke
Middle name
Last name Sumi

Organization

National Hospital Organization Minami Kyoto Hospital

Division name

Department of Respiratory Medicine

Zip code

6100113

Address

11 Naka Ashihara, Joyo City, Kyoto Prefecture

TEL

0774520065

Homepage URL


Email

kensukesumi@gmail.com


Sponsor or person

Institute

National Hospital Organization Minami Kyoto Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Minami Kyoto Hospital

Address

11 Naka Ashihara, Joyo City, Kyoto Prefecture

Tel

0774520065

Email

kensukesumi@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 22 Day


Related information

URL releasing protocol

https://www.jrs.or.jp/search/abstract/entry.php?id=30458

Publication of results

Unpublished


Result

URL related to results and publications

https://www.jrs.or.jp/search/abstract/entry.php?id=30458

Number of participants that the trial has enrolled

101

Results

The mean CRP of 101 patients increased significantly from 0.66 to 0.91 before and after the first vaccination, and from 0.74 to 0.97 after the second vaccination. However, only 3 of 101 patients developed a fever of 38 degrees centigrade or higher after vaccination, and respiratory and circulatory status was not significantly affected.

Results date posted

2023 Year 05 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

chronic respiratory failure

Participant flow

Vital signs and systemic symptoms of 101 patients with chronic respiratory failure up to 4 days after vaccination with the novel coronavirus vaccine. Vital signs, systemic symptoms, and various other adverse reactions were observed up to 4 days after vaccination.

Adverse events

none

Outcome measures

Vital signs, systemic symptoms

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 22 Day

Date of IRB

2021 Year 04 Month 14 Day

Anticipated trial start date

2021 Year 05 Month 24 Day

Last follow-up date

2022 Year 05 Month 24 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2021 Year 05 Month 22 Day

Last modified on

2023 Year 11 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050592


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name